2000
DOI: 10.1016/s0360-3016(00)00648-9
|View full text |Cite
|
Sign up to set email alerts
|

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
158
3
4

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 272 publications
(177 citation statements)
references
References 22 publications
9
158
3
4
Order By: Relevance
“…It has been reported that a pre-existing pulmonary disease predisposes the patient to manifestation of RP (Robnett et al, 2000;Inoue et al, 2001). In our patients' sample, 10 patients suffered from COPD.…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that a pre-existing pulmonary disease predisposes the patient to manifestation of RP (Robnett et al, 2000;Inoue et al, 2001). In our patients' sample, 10 patients suffered from COPD.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, dosimetric parameters, such as the mean lung dose, have been most consistently linked with the risk of pneumonitis in many studies [2][3][4][5][6]8]. Furthermore, several studies suggest that patients with relatively poor pre-RT lung function are more likely to experience toxicity than are patients with better lung function [7,9,23,24].…”
Section: Discussionmentioning
confidence: 99%
“…We are uncertain why we achieve different results in this regard, and this is a topic of ongoing study. A number of other research groups also did not find different rates of pneumonitis based on tumor location [7,30,31]. The model tested in this study was DVHbased, which discards all spatial information.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several of these clinical factors, such as gender (8,16,23,(36)(37)(38)(39)(40)(41)(42)(43), age (36)(37)(38)(39)(41)(42)(43)(44)(45)(46) and tobacco use (18,22,(36)(37)(38)45,47), may have an impact on RT-induced lung injury, and are not considered in our analysis. For the analysis of responders vs. non-responders, it is not possible to control for all of the clinical variables (such as rates of patients with SCLC, or early stage lesions) since the phenotype of responders and non-responders may be fundamentally different.…”
Section: Study Limitationsmentioning
confidence: 99%